160 GENES FOUND

? »

« prev | Page of 4 | next »

Show / hide columns »

XML | RDF | TAB

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Subcell

Cell line

Cancer

 

 

 

 

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ELANEElastase, neutrophil expressedCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
EPHA2EPH receptor A2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
RAS pathway related proteins
Tissue enhanced
ERBB2V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
F2Coagulation factor II (thrombin)Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched
FASNFatty acid synthaseCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
FDPSFarnesyl diphosphate synthaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
FGFR2Fibroblast growth factor receptor 2Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
FLT1Fms-related tyrosine kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Tissue enriched
FLT4Fms-related tyrosine kinase 4Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
FOLH1Folate hydrolase (prostate-specific membrane antigen) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
GAAGlucosidase, alpha; acidDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GANABGlucosidase, alpha; neutral ABEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
GARTPhosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetaseEnzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GGCXGamma-glutamyl carboxylaseDisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
GGPS1Geranylgeranyl diphosphate synthase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
GSRGlutathione reductaseCancer-related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Plasma proteins
Expressed in all
GSSGlutathione synthetaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC1Histone deacetylase 1Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC2Histone deacetylase 2Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HDAC3Histone deacetylase 3Enzymes
FDA approved drug targets
Expressed in all
HDAC6Histone deacetylase 6Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Expressed in all
HDAC9Histone deacetylase 9Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HMGCR3-hydroxy-3-methylglutaryl-CoA reductaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
HPD4-hydroxyphenylpyruvate dioxygenaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Group enriched
HPRT1Hypoxanthine phosphoribosyltransferase 1Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
HSD3B1Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
HSD3B2Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2Disease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Tissue enriched
IDEInsulin-degrading enzymeEnzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Expressed in all
IKBKBInhibitor of kappa light polypeptide gene enhancer in B-cells, kinase betaDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
IMPDH1IMP (inosine 5'-monophosphate) dehydrogenase 1Disease related genes
Enzymes
FDA approved drug targets
Expressed in all
IMPDH2IMP (inosine 5'-monophosphate) dehydrogenase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Expressed in all
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)Cancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Mixed
LCKLymphocyte-specific protein tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Tissue enhanced
LIPFLipase, gastricEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Mitochondrial proteins
Predicted membrane proteins
Mixed
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
Plasma proteins
RAS pathway related proteins
Expressed in all
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Cytoskeleton related proteins
Enzymes
FDA approved drug targets
RAS pathway related proteins
Expressed in all
METMet proto-oncogeneCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Mixed
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Expressed in all
MGAMMaltase-glucoamylase (alpha-glucosidase)Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Group enriched
MMEMembrane metallo-endopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMP10Matrix metallopeptidase 10 (stromelysin 2)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
MMP11Matrix metallopeptidase 11 (stromelysin 3)Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP15Matrix metallopeptidase 15 (membrane-inserted)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Mixed
MMP8Matrix metallopeptidase 8 (neutrophil collagenase)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Tissue enriched

« prev | Page of 4 | next »